FAGR Fagron SA

Disclosure of received notifications

Disclosure of received notifications

Regulated information

Nazareth (Belgium)/Rotterdam (The Netherlands), 24 July 2020

Disclosure of received notifications

Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron received notifications of Norges Bank.

Notifications of Norges Bank

  • On 20 July 2020, Fagron received a notification of Norges Bank that the total position (voting rights and equivalent financial instruments) had fallen below the disclosure threshold of 3% (the lowest threshold) on 17 July 2020 as the result of the disposal of voting securities or voting rights.
17 July 2020  
Voting rights1,803,2472.50%
Equivalent financial instruments (right to recall)297,5550.41%
Total number of voting rights2,100,8022.91%
  • On 23 July 2020, Fagron received a notification of Norges Bank that the total position (voting rights and equivalent financial instruments) had crossed the disclosure threshold of 3% on 22 July 2020 as the result of the acquisition of voting securities or voting rights.
22 July 2020  
Voting rights1,869,4252.59%
Equivalent financial instruments (right to recall)300,3540.42%
Total number of voting rights2,169,7793.01%
  • The notifications of Norges Bank can be viewed on investors.fagron.com via this .

In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.

For more information

Constantijn van Rietschoten

Chief Communications Officer

Tel. 85

Please open the link below for the press release:

EN
24/07/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Fagron SA

Fagron NV: 1 director

Five Directors at Fagron NV bought/sold 189,367 shares at between 16.230EUR and 20.506EUR. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over ...

 PRESS RELEASE

Fagron shareholders approve all voting items AGM

Fagron shareholders approve all voting items AGM Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 12 May 2025 – 7PM CET Fagron shareholders approve all voting items AGM Fagron, the leading global player in pharmaceutical compounding, held its annual general shareholders meeting today, where all the voting items were approved. ResolutionsThe annual general meeting approved, amongst other things, Fagron’s annual financial statements and dividend proposal of €0.35 per share for the fiscal year 2024, the remuneration policy and the appointment of the statutory auditor fo...

 PRESS RELEASE

Aandeelhouders Fagron keuren alle agendapunten van de jaarvergadering ...

Aandeelhouders Fagron keuren alle agendapunten van de jaarvergadering goed Gereglementeerde informatieNazareth (België)/Rotterdam (Nederland), 12 mei 2025 – 19:00u CET Aandeelhouders Fagron keuren alle agendapunten van de jaarvergadering goed Fagron, de toonaangevende mondiale speler in farmaceutische bereidingen, hield vandaag haar jaarlijkse algemene vergadering van aandeelhouders, waarbij alle ingediende voorstellen werden goedgekeurd. BesluitenDe jaarvergadering heeft onder andere Fagron’s jaarrekening en het dividendvoorstel van €0,35 per aandeel over het boekjaar 2024, het remunera...

Guy Sips ... (+7)
  • Guy Sips
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Kristof Samoy
  • Thomas Couvreur
  • Thomas Vranken
  • Wim Lewi
Thomas Vranken
  • Thomas Vranken

Fagron Capital Markets Day feedback

Yesterday, Fagron hosted a Capital Markets Day where it laid out its strategic priorities for 2030. We see the updated Compounding for Growth strategy as a natural extension of the successful current trajectory. Financial targets are set for HSD-LDD organic CER revenue growth, a 21.0% REBITDA margin by 2027 progressively increasing thereafter to 2030, =70% operating cash conversion, =50% FCF conversion and 3.5% maintenance capex. Management continues to expect solid organic growth across all reg...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch